Bob Blouin, PharmD

• Dean of Pharmacy
• Vaughn and Nancy Bryson Distinguished Professor

Effects of disease (infectious disease and trauma) on altered physiologic states (i.e., aging and obesity) and the expression and regulation of drug metabolizing enzymes (i.e., cytochrome P450, glucuronosul transferase, and glutathione transferase).

Moo Cho, PhD

• Professor

Targeted delivery of nucleic acids and proteins by means of synthetic or endogenous drug carriers.

Shawn Hingtgen, PhD

• Assistant Professor

Leaf Huang, PhD

• Distinguished Professor
• Director

Development of non-viral vectors for gene (including oligonucleotides) therapy; receptor mediated drug and vaccine targeting using self-assembled nanoparticles.

Michael Jay, PhD

• Other
• Chair

The application of pharmaceutical approaches to solve problems related to nuclear imaging and therapy, and the use of radioanalytical approaches to solve problems encountered in the development of novel formulations and drug delivery systems.

Rudolph Juliano, PhD

• Professor
• Boshamer Distinguished Professor, School of Pharmacy, School of Medicine

Regulation of signal transduction and cell growth by integrin-mediated cell adhesion, therapeutic drug design and delivery.

Richard Kowalsky, PharmD

• Associate Professor

Dr. Kowalsky also manages the nuclear pharmacy lab in nuclear medicine at UNC Hospitals.

Sam Lai, PhD

• Assistant Professor

Infectious diseases; drug delivery to and imaging of metastatic tumors.

Russell Mumper, PhD

• John McNeill Distinguished Professor
• Vice Dean

1) Nanotemplate engineering of nano-based detection devices and cell-specific nanoparticles for tumor and dendritic cell targeting and vaccines. Current projects relate to using nanotechnology to target and overcome multi-drug resistant cancer, and as vaccine delivery systems for HIV proteins and adjuvants; 2) Biocompatibility, hemocompatibility, and toxicology of nanoparticles and nanomaterials; 3) Drug-polymer conjugates; 4) Mucoadhesive gels, thin-films, and intravaginal rings for (trans)mucosal delivery of drugs, vaccines, and microbicides; 5) Anticancer and anti-inflammatory properties of berries and berry extracts.

Philip C. Smith, PhD

• Associate Professor

Correlating pharmacokinetics and metabolism of drugs with their pharmacodynamics and toxicity. Research efforts in this area include in vitro studies and in vivo animal experiments aimed at understanding mechanisms of processes that influence drug disposition and toxicity.

Xiao Xiao, PhD

• Fred Eshelman Distinguished Professor of Gene Therapy
• Vice Chair, Division of Molecular Pharmaceutics